1. Home
  2. BLCO vs MAIN Comparison

BLCO vs MAIN Comparison

Compare BLCO & MAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • MAIN
  • Stock Information
  • Founded
  • BLCO 1853
  • MAIN 2007
  • Country
  • BLCO Canada
  • MAIN United States
  • Employees
  • BLCO N/A
  • MAIN N/A
  • Industry
  • BLCO Ophthalmic Goods
  • MAIN Finance/Investors Services
  • Sector
  • BLCO Health Care
  • MAIN Finance
  • Exchange
  • BLCO Nasdaq
  • MAIN Nasdaq
  • Market Cap
  • BLCO 4.9B
  • MAIN 5.3B
  • IPO Year
  • BLCO 2022
  • MAIN 2007
  • Fundamental
  • Price
  • BLCO $14.66
  • MAIN $64.50
  • Analyst Decision
  • BLCO Hold
  • MAIN Hold
  • Analyst Count
  • BLCO 12
  • MAIN 5
  • Target Price
  • BLCO $15.55
  • MAIN $53.60
  • AVG Volume (30 Days)
  • BLCO 865.0K
  • MAIN 474.1K
  • Earning Date
  • BLCO 07-30-2025
  • MAIN 08-07-2025
  • Dividend Yield
  • BLCO N/A
  • MAIN 6.51%
  • EPS Growth
  • BLCO N/A
  • MAIN 7.71
  • EPS
  • BLCO N/A
  • MAIN 5.90
  • Revenue
  • BLCO $4,829,000,000.00
  • MAIN $546,466,000.00
  • Revenue This Year
  • BLCO $6.99
  • MAIN $3.83
  • Revenue Next Year
  • BLCO $5.46
  • MAIN $1.43
  • P/E Ratio
  • BLCO N/A
  • MAIN $10.94
  • Revenue Growth
  • BLCO 11.94
  • MAIN 6.79
  • 52 Week Low
  • BLCO $10.45
  • MAIN $45.00
  • 52 Week High
  • BLCO $21.69
  • MAIN $66.39
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 68.51
  • MAIN 65.67
  • Support Level
  • BLCO $13.81
  • MAIN $63.25
  • Resistance Level
  • BLCO $14.49
  • MAIN $66.00
  • Average True Range (ATR)
  • BLCO 0.42
  • MAIN 1.12
  • MACD
  • BLCO 0.00
  • MAIN -0.04
  • Stochastic Oscillator
  • BLCO 76.70
  • MAIN 62.62

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About MAIN Main Street Capital Corporation

Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancing, and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants, and other securities of the lower middle market and middle market companies based in the United States. Business functioned through the U.S. region and it derives the majority of its income from the source of fees, commission, and interest.

Share on Social Networks: